Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: Results of an open label randomized trial

H. Amer, M. D. Griffin, M. D. Stegall, F. G. Cosio, W. D. Park, W. K. Kremers, R. L. Heilman, M. J. Mazur, K. Hamawi, T. S. Larson, R. Kumar

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: Results of an open label randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences